MARATTO

review · Journal of Pharma Insights and Research.

A Review on Artificial Intelligence and Point-of-Care Diagnostics to Combat Antimicrobial Resistance in Resource-Limited Healthcare Settings like Nigeria

202510 citationsOpen accessLadoke Akintola University of Technology

Abstract

The global crisis of antimicrobial resistance (AMR) demands innovative diagnostic solutions, particularly in resource-limited settings. This paper examines the integration of artificial intelligence (AI) with point-of-care (POC) diagnostics for AMR detection in Nigerian healthcare systems. A systematic search of literature published between 2018 and 2024 was conducted across major databases including PubMed, Scopus, and Web of Science, yielding 127 relevant studies. Current evidence indicates that AI-enabled POC platforms demonstrate 92-97% accuracy in pathogen identification and can reduce diagnostic turnaround time from 48-72 hours to 2-4 hours. Machine learning algorithms, particularly deep neural networks and random forests, have shown promising results in predicting resistance patterns with 89% sensitivity and 94% specificity. Implementation challenges in Nigeria include limited infrastructure, with only 23% of healthcare facilities having adequate diagnostic capabilities, and a significant workforce shortage, with a ratio of 1 laboratory scientist to 20,000 patients. Economic analyses suggest that AI-POC integration could reduce diagnostic costs by 60% and decrease inappropriate antibiotic prescriptions by 40%. Literature indicates that AI-augmented POC diagnostics represent a viable solution for enhancing AMR surveillance and antimicrobial stewardship in Nigeria.

Research topics

  • COVID-19 diagnosis using AI
  • Antibiotic Use and Resistance

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.69613/reeh4906

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.